BAM
DTIL icon

Belpointe Asset Management’s Precision BioSciences DTIL Stock Holding History

Belpointe Asset Management’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-237
Closed -$8.45K – 3752
2022
Q4 		$8.45K Buy
+237
New +$9.37K ﹤0.01% 2709

Other funds holding DTIL

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Belpointe Asset Management's DTIL Position: Q1 2023 in Review

Belpointe Asset Management sold out of Precision BioSciences (DTIL) in Q1 2023, closing a stake of 237 shares — an estimated $8.45K sold.

Belpointe Asset Management first reported a position in DTIL in Q4 2022 and held it in 1 quarter. The position peaked at $8.45K in Q4 2022. 86 funds tracked by Wall St. Rank hold DTIL as of Q1 2023.

  • Belpointe Asset Management reported no remaining Precision BioSciences position as of Q1 2023 after selling out during the quarter.
  • Belpointe Asset Management sold 237 Precision BioSciences shares in Q1 2023, an estimated $8.45K.
  • Belpointe Asset Management first reported a position in Precision BioSciences in Q4 2022 and held it in 1 quarter.
  • Belpointe Asset Management's Precision BioSciences position peaked at $8.45K in Q4 2022.
  • 86 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2023.

Based on Belpointe Asset Management's 13F filing for Q1 2023, filed 15 May 2023.